Skip to content
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · LARGE CAP

InMode Ltd. INMD

9 fiscal years on record · USD · FY2025 reported · SEC filings only
$370.5M
▼ 6.2% YoY
$93.8M
▼ 48.2% YoY
$84.3M
▼ 36.1% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 370.5M
Revenue, FY2025 · full 9-year series below
Revenue $M Net income $M
FY2025 · Revenue 370.5 · Net income 93.8
200M400M
2017202020232025
Compound annual growth
−6.6%
+12.4%
−16.6%
−8.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +12.4% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

25 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 23.0% · Net 25.3%
20%40%
201720212025
ROE
FY2025 · ROE 13.5%
20%40%60%
201720212025
Three returns, three denominators.

Each USD of equity produced 14 cents of profit this year.

Cash & shareholders

USD 126.1M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 84.3
100M200M
201720212025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 126.1
100M200M
202020212022202320242025

USD 126.1M in buybacks — 134% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 766.4M
EquityUSD 683.2M
CashUSD 302.5M
Current ratio9.88×

Equity funds 89% of total assets.

The 9-year record

9 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
INMD, 9-year financial record
Metric 202520242023202220212020201920182017
Revenue $B0.40.40.50.50.40.20.20.10.1
Operating income $B0.10.10.20.20.20.10.10.00.0
EBITDA $B0.10.10.20.20.20.10.10.00.0
Income tax $B0.0−0.00.00.00.00.00.00.00.0
Net income $B0.10.20.20.20.20.10.10.00.0
Free cash flow $B0.10.10.20.20.20.10.10.00.0
EPS, diluted $1.432.252.301.891.920.890.800.620.26
Dividend / sh $◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————
ROE %13.524.329.533.349.334.955.871.345.3
Shares out B0.060.070.080.080.080.040.030.03◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures · 2 divergences in 43 reconciliationsAUDITED

Reconciled in 7 of the 9 fiscal years we could check. 2 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 22 checks were skipped: the balance sheet is not tagged before 2018. 10 checks were skipped: EPS is not tagged before 2017. 10 checks were skipped: revenue is not tagged before 2017.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures2 divergent
ActivityElectromedical & Electrotherapeutic Apparatus
Listed onNASDAQ
Incorporated inoutside the United States — SEC code L3
Fiscal year endsDecember 31
Data on record since2017

Share this section

Download image